Skip to main content

Table 6 Incidence of serious adverse drug reactions

From: Safety and effectiveness of intravenous abatacept for polyarticular-course juvenile idiopathic arthritis: An all-case postmarketing surveillance study

Serious adverse drug reactions*

Safety analysis population

 

Overall (%)

n = 82

Continuously treated patients (%)

n = 17

Newly treated patients (%)

n = 65

Number of patients who experienced serious adverse drug reactions (%)

2

(2.4)

0

(0.0)

2

(3.1)

Number of serious adverse drug reactions

 

3

0

3

Infections and infestations

2

(2.4)

0

(0.0)

2

(3.1)

 

Bronchitis

1

(1.2)

0

(0.0)

1

(1.5)

 

Pneumonia

1

(1.2)

0

(0.0)

1

(1.5)

 

Varicella

1

(1.2)

0

(0.0)

1

(1.5)

  1. *Serious adverse drug reactions were coded using MedDRA version 24.0